Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0HZ7J
|
|||
| Drug Name |
N-alkyl-4-oxazolecar boxamide derivative 2
|
|||
| Synonyms |
PMID26413912-Compound-93
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
ALLERGAN, INC. WOODWARD, David F. MARTOS, Jose L. CARLING, William R. POLOSO, Neil J. WANG, Jenny W
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C31H44N4O7S
|
|||
| Canonical SMILES |
CCS(=O)(=O)NC(=O)CCC1=C(C=C(C=C1)OC)C(=O)N2CCCC2C3=NC(=CO3)C(=O)NCCCCC4CCCCC4
|
|||
| InChI |
1S/C31H44N4O7S/c1-3-43(39,40)34-28(36)17-15-23-14-16-24(41-2)20-25(23)31(38)35-19-9-13-27(35)30-33-26(21-42-30)29(37)32-18-8-7-12-22-10-5-4-6-11-22/h14,16,20-22,27H,3-13,15,17-19H2,1-2H3,(H,32,37)(H,34,36)/t27-/m0/s1
|
|||
| InChIKey |
CARRKGKFLQFOPT-MHZLTWQESA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.